Category: Federal

In What Could be a First, Drug Maker Gives Providers Deadline to Request 340B Overcharge Refunds

July 13, 2023 Tom Mirga, Editor at Large Views

Drug manufacturer VistaPharm says requests for refunds for 340B overcharges must be received before Aug. 31. No manufacturer is believed to have set such a deadline before, and it's unclear if VistaPharm is the first to say refunds are available upon request.

Generic and over-the-counter drug manufacturer VistaPharm said in a public notice this week that it has identified 340B covered entities [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Some 340B Hospitals Might Get Less Than Expected Under Fix for Illegal Medicare Drug Payment Cuts

July 13, 2023 Rich Daly, Editor in Chief Views

CMS's projections of what it owes 340B hospitals for unlawful Medicare Part B drug payment cuts might not align with what health systems and hospitals expect to get.

A $9 billion Medicare proposal to repay 340B hospitals for unlawful Part B drug payment cuts includes a spreadsheet showing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers March to Capitol Hill for Second Straight Year to ‘Defend 340B’

July 13, 2023 William Newton, Associate Editor/Senior Writer Views

Around 50 340B provider advocates marched to the U.S. Capitol yesterday to urge Congress to defend the drug pricing program. Nonprofit group CV340B organized the demonstration.

On a sunny, humid, 92-degree afternoon in Washington, D.C., over 50 safety-net health care providers marched to the U.S. Capitol [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Providers Celebrate 340B Medicare Drug Payment Fix, Object to How It’s Funded

July 11, 2023 Rich Daly, Editor in Chief Views

CMS today formally published in the Federal Register its proposed remedy for illegal Medicare Part B drug payments cuts for many 340B hospitals from 2018 through 2022.

Provider groups widely celebrated the Medicare proposal to provide a $9 billion lump sum payment to reimburse 340B hospitals for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Ease 340B Requirements for Generic Drugs to Ease Shortages, Trade Group Tells Congressional Committee Chairs

July 11, 2023 Tom Mirga, Editor at Large Views

Congress should ease 340B requirements for generic drugs to help stem shortages, the trade group for makers of the drugs said in a July 7 white paper.

Low-cost generic drugs should get an exemption from the 340B drug pricing program to help reduce drug shortages, the U.S. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

As Congress Weighs 340B Changes, Leading HIV/AIDS Group Urges it to Support the Program

July 11, 2023 Rich Daly, Editor in Chief Views

Washington Examiner, a conservative news outlet, published an op-ed by AHF President Michael Weinstein urging Congress to protect 340B from the drug industry.

A leading not-for-profit HIV and AIDS treatment organization amplified its 340B advocacy recently with an op-ed in a Washington, D.C., [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Proposes $9 Billion in Lump Sum Payments to Reimburse Hospitals for Past 340B Part B Drug Payment Cuts

July 7, 2023 Rich Daly, Editor in Chief Views

CMS late this afternoon proposed how it will repay 340B hospitals for $10.5 billion in illegal Medicare Part B drug payment cuts.

The U.S. Centers for Medicare & Medicaid Services plans to provide lump sum Medicare Part B drug payments to 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

White House Clears CMS to Issue Proposed Fix for 340B Hospital Part B Drug Payment Cuts

July 7, 2023 Rich Daly, Editor in Chief Views

OMB clearance of CMS Part B remedy proposal

The White House Office of Management and Budget yesterday cleared CMS to issue its proposed remedy for five year's worth of Medicare Part B drug payment cuts for 340B hospitals.

The White House yesterday gave the U.S. Centers for Medicare & Medicaid Services the go-ahead to publish its proposed remedy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Prime Vendor Apexus and AIDS Healthcare Foundation Are Trying to Settle Lawsuit Over Sub-Ceiling Price Discounts

July 7, 2023 William Newton, Associate Editor/Senior Writer Views

AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.

Apexus, the federally contracted 340B prime vendor, and AIDS Healthcare Foundation are meeting with a mediator to try to settle [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Issues Remain Unresolved in Latest CMS Medicare Drug Price Negotiation Guidance

July 7, 2023 Rich Daly, Editor in Chief Views

CMS said in its latest Medicare Drug Price Negotiation Program guidance it still working on a process to allow manufacturers to avoid providing a 340B price and a negotiated fair price for the same drug.

The latest guidance to implement first-time drug price negotiation under Medicare said federal officials still are looking for a process [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live